This investigation examined the association between PLA2G16 expression levels and prognostic outcomes in individuals with pancreatic cancer, with particular emphasis on the responsiveness of pancreatic cancer cells to gemcitabine. Here, PLAAT3 is linked to pancreatic neoplasm.